Acquisition of conditioned reward blocked by intra-accumbens infusion of PD-140548, a CCK(A) receptor antagonist

Pharmacology Biochemistry and Behavior

Volumn 55, Issue 3, 1996, Pages 439-444

  Josselyn, Sheena A ^a   Vaccarino, Franco J ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

CCK(A) receptors; Conditioned reward; Nucleus accumbens; PD 140548; Reward related learning

Indexed keywords

ALPHA METHYL N [(TRICYCLO[3.3.1.1 3,7]DEC 2 YLOXY)CARBONYL]TRYPTOPHYL DEXTRO 3 BENZYL BETA ALANINE; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONDITIONING; CONTROLLED STUDY; HISTOLOGY; INTRACEREBRAL DRUG ADMINISTRATION; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; MICROINJECTION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REWARD;

ANIMALS; CONDITIONING, OPERANT; HUMANS; INDOLES; MICROINJECTIONS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CHOLECYSTOKININ A; RECEPTORS, CHOLECYSTOKININ;

ANIMALIA;

EID: 0030297429     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00115-3     Document Type: Article

References (34)

1. 1. Aulisi, E. F.; Hoebel, B. G. Rewarding effects of amphetamine or cocaine in the nucleus accumbens and block by alpha-flupenthixol. Soc. Neurosci. Abstr. 9:121; 1983.
2. 2. Beninger, R. J. The role of dopamine in locomotor activity and learning. Brain Res. Rev. 6:173-196; 1983.
3. 3. Beninger, R. J. Receptor subtype-specific dopamine agonists and antagonists and conditioned behavior. In: Willner, P.; Scheel-Kruger, J., eds. The mesolimbic dopamine system: From motivation to action. New York: John Wiley and Sons; 1991:273-299.
4. 4. Beninger, R. J.; Hahn, B. L. Pimozide blocks establishment but not expression of amphetamine-produced environment-specific conditioning. Science 220:1304-1306; 1983.
5. 5. Bindra, D. A motivational view of learning, performance, and behavior modification. Psychol. Rev. 81:199-213; 1974.
6. 6. Cervo, L.; Samamin, R. Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference. Brain Res. 673:242-250; 1995.
7. 7. Crawley, J. N. Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway. J. Neurosci. 12:3380-3393; 1992.
8. 8. Crawley, J. N.; Hommer, D. W.; Skirboll, L. R. Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates the dopamine induced hyperlocomotion in the rat. Brain Res. 335:337-341; 1985.
9. 9. Crawley, J. N.; Stivers, J. A.; Hommer, D. W.; Skirboll, L. R.; Paul, S. M. Antagonists of central and peripheral behavioral effects of cholecystokinin octapeptide. J. Pharmacol. Exp. Ther. 236:320-330; 1986.
10. 10. Dourish, C. T.; Hill, D. R. Classification and function of CCK receptors. Trends Pharmacol. Sci. 8:207-208; 1987.
11. 11. Emson, P. C.; Rehfeld, J. F.; Rossor, M. N. Distribution of cholecystokinin-like peptides in the human brain. J. Neurochem. 38:1177-1179; 1982.
12. A receptor antagonist devazepide. Eur. J. Pharmacol. 197:229-230; 1991.
13. B receptor antagonists. Brain Res. 572:208-215; 1992.
14. 14. Hoffman, D. C.; Beninger, R. J. The effects of pimozide on the establishment of conditioned reinforcement as a function of the amount of conditioning. Psychopharmacology 87:454-460; 1985.
15. 15. Hokfelt, T.; Holets, V. R.; Staines, W.; Meister, B.; Melander, T.; Schalling, M.; Schultzberg, M.; Freedman, J.; Bjorkland, H.; Olson, L.; Lindh, B.; Elfvin, L. G.; Lundberg, J. M.; Lindgren, J. A.; Samuelsson, B.; Pernow, B.; Terenius, L.; Post, C.; Everitt, B.; Goldstein, M. Co-existence of neuronal messengers: An overview. Prog. Brain Res. 68:33-70; 1986.
16. 16. Hokfelt, T.; Skirboll, L.; Rehfeld, J. F.; Goldstein, M.; Markey, K.; Dann, O. A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contain cholecystokinin-like peptide: Evidence from immunohistochemistry combined with retrograde tracing. Neuroscience 5:2093-2124; 1980.
17. 17. Innis, R. B.; Snyder, S. H. Distinct cholecystokinin receptors in brain and pancreas. Proc. Natl. Acad. Sci. USA 77:6917-6921; 1980.
18. 18. Josselyn, S. A.; Beninger, R. J. Neuropeptide Y: Intra-accumbens injections produce a place preference that is blocked by cis-flupenthixol. Pharmacol. Biochem. Behav. 46:543-552; 1993.
19. A receptor antagonist impairs the acquisition of conditioned reward and conditioned activity. Psychopharmacology 123:131-143; 1996.
20. 20. Mackintosh, N. J. The psychology of animal learning. London: Academic Press; 1974.
21. 21. Marshall, F. H.; Barnes, S.; Hughes, J.; Woodruff, G. N.; Hunter, J. C. Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms. J. Neurochem. 56:917-922; 1991.
22. 22. Moran, T. H.; Robinson, P. H.; Goldrich, M. S.; McHugh, P. R. Two brain cholecystokinin receptors: Implications for behavioral actions. Brain Res. 362:175-179; 1986.
23. 23. Paxinos, G.; Watson, C. The rat brain in stereotaxic co-ordinates. 2nd ed. Sydney: Academic Press; 1986.
24. 24. Phillips, G. D.; LeNoury, J.; Wolterink, G.: Donsellar-Wolterink, J.; Robbins, T. W.; Everitt, B. J. Cholecystokinin-dopamine interactions within the nucleus accumbens in the control over behavior by conditioned reinforcement. Behav. Brain Res. 55:223-231; 1993.
25. B receptor agonists and antagonists. Mol. Neuropharmacol. 1:211-218; 1992.
26. 26. Skirboll, L. F.; Grace, A. A.; Hommer, D. W.; Rehfeld. J. F.; Goldstein, M.; Hokfelt, T.; Bunney, B. S. Peptide-monoamine coexistence: Studies of the actions of CCK-like peptides on the electrical activity of midbrain DA neurons. Neuroscience 6:2111-2114; 1981.
27. 27. Studler, J. M.; Reibaud, M.; Herve, D.; Blanc, G.; Glowinski, J.; Tassin, J. P. Opposite effects of sulphated cholecystokinin on DA-sensitive adenylate cyclase in two areas of the rat nucleus accumbens. Eur. J. Pharmacol. 126:128-128; 1986.
28. 28. Taylor J. R.; Robbins, T. W. Enhanced behavioral control by conditioned reinforcers following microinjection of d-amphetamine into the nucleus accumbens. Psychopharmacology 84:405-412; 1984.
29. 29. Vaccarino, F. J. Nucleus accumbens dopamine-CCK interactions in psychostimulant reward and related behaviors. Neurosci. Biobehav. Rev. 18:207-214; 1994.
30. 30. Vaccarino, F. J.; Rankin, J. Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity; evidence for rostral-caudal differences in accumbens CCK function. Behav. Neurosci. 103:831-836; 1989.
31. 31. Wang, R. Y.; Hu, X. T. Does cholecystokinin potentiate dopamine action in the nucleus accumbens? Brain Res. 380:363-367; 1986.
32. 32. Wank, S. A.; Pisegna, J. R.; DeWeerth, A. Brain and gastrointestinal cholecystokinin receptor family: Structure and functional expression. Proc. Natl. Acad. Sci. USA 89:8670-8691; 1992.
33. 33. White, F. J.; Wang, R. Y. Interactions of CCK octapeptide and dopamine on nucleus accumbens neurons. Brain Res. 300:161-166; 1984.
34. 34. Winer, B. J. Statistical principles in experimental design. New York: McGraw-Hill; 1971.